Company Search:
Advanced Search
Sponsored Links
Aerie Pharmaceuticals Inc Company Snapshot
Aerie Pharmaceuticals Inc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Aerie Pharmaceuticals Inc with three other companies in this sector in UNITED STATES : Flexion Therapeutics Inc (2019 sales of $72.96 million of which 100% was Pharmaceutical), Theravance Biopharma Inc ($73.41 million of which 100% was Human Therapeutics), and Vivus, Inc. ($69.76 million of which 100% was Development and commercialization of nov).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Aerie Pharmaceuticals Inc
  Stock Performance Chart for Aerie Pharmaceuticals Inc
  Stock Data: Recent Stock Performance:
  Current Price (8/7/2020): 12.61
(Figures in U.S. Dollars)
1 Week 9.1%   13 Weeks -5.4%  
4 Weeks -17.4%   52 Weeks -46.4%  
Aerie Pharmaceuticals Inc Key Data:
  Ticker: AERI Country: United States
  Exchanges: NAS Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2019 Sales 69,888,000
(Year Ending Jan 2020).
Employees: 380
  Currency: U.S. Dollars Market Cap: 586,533,331
  Fiscal Yr Ends: December Shares Outstanding: 46,513,349
  Share Type: Common Closely Held Shares: 1,831,389
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.